ATYR FY 2018 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$746,000

Operating Income

-$33M

Net Income

-$35M

EPS (Diluted)

$-16.13

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$53M

Total Liabilities

$19M

Stockholders' Equity

$34M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$746,000	-$713,000	-4.6%
Operating Income	-$33M	-$47M	+30.4%
Net Income	-$35M	-$48M	+28.4%